Cytogenetic and antineoplastic effects by newly synthesised steroidal alkylators in lymphocytic leukaemia P388 cells in vivo

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 746, Issue 1, 2012, Pages 1-6

  Mourelatos, C ^a   Kareli, D ^a   Dafa, E ^a   Argyraki, M ^a   Koutsourea, A ^b   Papakonstantinou, I ^b   Fousteris, M ^b   Pairas, G ^b   Nikolaropoulos, S ^b   Lialiaris, Th S ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Leukaemia P388; Proliferation rate index (PRI); Sister chromatid exchange (SCE); Steroidal alkylator; Survival time; Synthesis

Indexed keywords

4 N,N BIS (2 CHLOROETHYL)AMINOPHENYL ACETATE; 4 N,N BIS (2 CHLOROETHYL)AMINOPHENYL BUTYRATE; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CHOLESTANE DERIVATIVE; ESTER DERIVATIVE; STEROID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOGENETICS; DRUG STRUCTURE; DRUG SYNTHESIS; ESTERIFICATION; IN VIVO STUDY; INOCULATION; LEUKEMIA CELL; LYMPHATIC LEUKEMIA; MOUSE; NONHUMAN; P388 CELL; PARAMETERS; PRIORITY JOURNAL; PROLIFERATION RATE INDEX; SISTER CHROMATID EXCHANGE; SURVIVAL TIME;

ALKYLATING AGENTS; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; LEUKEMIA P388; MICE; NITROGEN MUSTARD COMPOUNDS; SISTER CHROMATID EXCHANGE; STEROIDS;

MUS;

EID: 84860381345     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2011.12.032     Document Type: Article

References (31)

1. Karapidaki I., Papageorgiou A., Geromichalos G., Fousteris M., Papaconstadinou I., Pairas G., Koutsourea A., Mourelatos D., Nikolaropoulos S., Lialiaris T. Cytogenetic and antineoplastic effects of modified steroidal alkylators. Genet. Test. Mol. Biomarkers 2010, 14(1):93-97.
2. Wasan H., Waxman J. Cell Proliferation in Cancer Regulatory Mechanisms of Neoplastic Cell Growth 1996, 260-281. Oxford University Press, Oxford. L.L. Pusztai, C.E. Lewis, E. Yai (Eds.).
3. Karapidaki I., Bakopoulou A., Papageorgiou A., Iakovidou Z., Mioglou E., Nikolaropoulos S., Mourelatos D., Lialiaris T. Genotoxic cytostatic antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters. Mutat. Res. 2009, 675:51-59.
4. Hussein A., Mioglou E., Papageorgiou A., Karapidaki I., Iakovidou-Kritsi Z., Lialiaris T., Xrysogelou E., Camoutsis C., Mourelatos D. Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic and antineoplastc activity. In Vivo 2007, 21:389-395.
5. Goto K., Maeda S., Kano Y., Sugiyama T. Factors involved in the differential Giemsa staining of sister chromatids. Chromosoma 1978, 66(4):351-359.
6. Raptopoulou C.P., Paschalidou S., Pantazaki A.A., Terzis A., Perlepes S.P., Lialiaris T., Bakalbassis E.G., Mrozinski J., Kyriakidis D.A. Bis(acetato)bis(1-methyl-4 5-diphenylimidazole)copper(II): preparation, characterization, crystal structure, DNA strand breakage and cytogenetic effect. J. Inorg. Biochem. 1998, 71:15-27.
7. Lialiaris T., Mourelatos D., Stergiadou H.C., Constantinidou H.A. Cytogenetic study for possible mutagenic activity induced by ice-nucleation bacteria or their metabolic products in human lymphocytes in vitro. Mutat. Res. 1990, 242(2):163-168.
8. Lialiaris T., Mourelatos D., Boutis L., Papageorgiou A., Christianopoulou M., Papageorgiou V., Dozi-Vassiliades J. Comparative study on cytogenetic effects by diplatinum complexes of the ligands of naphthazarine and squaric acid in human lymphocytes. J. Pharmacol. Exp. Ther. 1989, 251(1):368-371.
9. Lialiaris T.S., Pantazaki A.A., Papachristou F.E., Lyratzopoulos E., Natsis K., Kortsaris A.H. The mutagenic potential of vitamin C on human lymphocytes and native nucleic acids. J. Biol. Res. Thessalon. 2007, 8:189-197.
10. Mourelatos D., Dozi-Vassiliades J., Kotsis A., Gourtsas C. Enhancement of cytogenetic damage and of antineoplastic effect by caffeine in Ehrlich ascites tumour cells treated with cyclophosphamide in vivo. Cancer Res. 1988, 48:1129-1131.
11. Karayiani V., Mioglou E., Iakovidou Z., Mourelatos D., Fousteris M., Koutsourea A., Arsenou E., Nikolaropoulos S. A new approach for evaluating in vivo anti-leukemic activity using the SCE assay an application on three newly synthesized antitumour steroidal esters. Mutat. Res. 2003, 535:79-86.
12. Caglioti L., Grasselli P., Giordana M. Modification of the Bamford-Stevens reaction: a new route to 7-dehydrocholesterol. Chim. Ind. 1963, 45:559-560.
13. Fousteris M.A., Koutsourea A.I., Arsenou E.S., Papageorgiou A., Mourelatos D., Nikolaropoulos S. Antileukemic and cytogenetic effects of modified and non-modified esteric steroidal derivatives of 4-methyl-3-bis(2-chloroethyl)amino benzoic acid (4-Me-CABA). Anticancer Res. 2002, 22:2293-2300.
14. Wang Y., Yang H., Li L., Wang H., Xia X., Zhang C. Biomarkers of chromosomal damage in peripheral blood lymphocytes induced by polycyclic aromatic hydrocarbons: a meta-analysis. Int. Arch. Occup. Environ. Health 2012, 85:13-25.
15. Digkas E.N., Chrisafi S., Passadaki T., Tsalkidis A., Hatzimichail A., Vargemezis V., Lialiaris T.S. In vitro and in vivo cytogenetic effects of recombinant human erythropoietin on the frequency of sister chromatid exchanges alone or in combination with mitomycin C. Chemotherapy 2010, 56(3):239-247.
16. Lialiaris T.S., Papachristou F., Mourelatos C., Simopoulou M. Antineoplastic and cytogenetic effects of chlorpromazine on human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo. Anti-Cancer Drugs 2009, 20(8):746-751.
17. Mpountoukas P., Pantazaki A., Kostareli E., Christodoulou P., Kareli D., Poliliou S., Mourelatos C., Lambropoulou V., Lialiaris T. Cytogenetic evaluation and DNA interaction studies of the food colorants amaranth, erythrosine and tartrazine. Food Chem. Toxicol. 2010, 48(10):2934-2944.
18. Goldin A., Sofina Z., Cyrkin A. Experimental evaluation of antitumour drugs in the USA and USSR and clinical correlations. Natl. Cancer Inst. Mongr. 1980, 55:25-26.
19. Mourelatos D. Chromosome study as predictor of chemoresponse of tumours. Cancer J. 1996, 9(3):136-141.
20. Grieco P., Oguri T., Wang C.-L., Williams E. Stereochemistry and total synthesis of (±)-Ivanulin. J. Org. Chem. 1977, 42:4113-4118.
21. Dauben W., Fullerton D. Steroids with abnormal internal configuration. A stereospecific synthesis of 8α-methyl steroids. J. Org. Chem. 1971, 36:3277-3282.
22. Koutsourea A., Arsenou E., Fousteris M., Nikolaropoulos S. Synthetic approaches for the synthesis of a cytostatic steroidal B-D bilactam. Steroids 2003, 68:659-666.
23. Koutsourea A., Fousteris M., Arsenou E., Papageorgiou A., Nikolaropoulos S. Rational design, synthesis and in vivo evaluation of the antileukemic activity of six new alkylating steroidal esters. Bioorg. Med. Chem. 2008, 16:5207-5215.
24. Strazzolini P., Giumanini G., Runcio A., Scuccato M. Experiments on the Chaperon effect in the nitration of aromatics. J. Org. Chem. 1998, 63:952-958.
25. Fousteris M., Koutsourea A., Arsenou E., Papageorgiou A., Mourelatos D., Nikolaropoulos S. Structure-antileukemic activity relationship study of B and D-ring modified and non-modified steroidal esters of chlorambucil. Anti-Cancer Drugs 2006, 17:511-519.
26. Wall M.E., Abernethy J.R.S., Caroll E.I., Taylor D.J. The effects of some steroidal alkylating agents on experimental animal mammary tumor and leukemia systems. J. Med. Chem. 1969, 12:810-818.
27. Schmidt-Thome J. The Beckmann rearrangement of 20-oxo-steroid oximes. Chem. Ber. 1955, 88:895-900.
28. Regan B.M., Hayes F.N. 17 and 17α-aza-d-homo steroids. J. Am. Chem. Soc. 1956, 78:639-643.
29. 5-steroidal substrates. Steroids 2003, 68:407-414.
30. 5,7-steroidal hormones. J. Org. Chem. 1951, 1126-1133.
31. Dauben W., Eastham J., Micheli R. A new method for the preparation of 7-dehydrocholesterol. J. Am. Chem. Soc. 1951, 73(9):4496.